Health agencies worldwide have issued updated warnings about medications that may raise the risk of blood clots, heart attacks, or strokes. Headlines about “clots” often cause fear, but the reality is “more complex—and far more useful—than simply declaring that ‘pills cause clots.’” Regulators continue to monitor medicines and update guidance when new evidence appears.
Organizations such as the FDA and EMA review clinical studies and real-world reports before taking action. Some drugs have been reviewed because of “potential links to blood clot formation,” but this does not mean they are unsafe for everyone. Experts emphasize that patients should not stop treatment suddenly and that “the risks and benefits must be carefully weighed.”
A blood clot, or thrombus, is part of normal healing, but it becomes dangerous when it forms inside blood vessels. Deep vein thrombosis can cause “swelling, pain, and redness,” while a clot that reaches the lungs becomes “a life-threatening emergency.” Clots in arteries can block blood flow to the heart or brain, leading to heart attacks or strokes.
Estrogen-containing contraceptives can slightly increase clot risk, though for most young women the absolute risk remains low. NSAIDs such as ibuprofen may raise cardiovascular risk when used long term or at high doses. Certain weight-loss drugs and unregulated supplements have also been linked to heart strain, highlighting the importance of medical supervision. During COVID-19, rare clotting events prompted agencies to update safety advice.
Overall, medication-related clots are uncommon, and everyday factors like immobility, smoking, obesity, or age often play a larger role. Patients should know warning signs and seek urgent care if symptoms appear. Most importantly, “they should not stop the medication abruptly without speaking to a healthcare provider,” as informed discussions help reduce fear and support safe treatment.
